Who this is for
People in the UK considering ibogaine, carers and supporters exploring options, and clinicians or advocates seeking clear summaries. If you are looking for cost or service directories, practical travel guidance and treatment-cost snapshots are discussed on related pages; for an overview of treatment cost context we include links such as the independent treatment-cost resource that compiles pricing comparisons and traveller information on overseas services via the site that tracks service pricing.
We also link to external authoritative sources when describing evidence quality; for example, systematic-review guidance on evidence grading is consistent with methods outlined by major research bodies such as the Cochrane Collaboration (Cochrane on systematic reviews) and public-health summaries from national health services (NHS guidance).
Independent by design
Civic Halcyon is an independent information resource and Gentle Clearing 51 publishes this material to improve public understanding. This site does not act as a clinic, medical provider, or licensed treatment centre, and its content is not medical or legal advice.
For questions about our services page or to explore what we offer, see our brief services overview on the services page; for a broader directory and cost context among overseas providers we reference external service-cost resources such as the treatment-cost tracker that summarises pricing and facility differences at ibogaine treatment cost listings.
If you arrived here from another section and want the site's main landing summaries, follow editorial pathways back to the site’s opening pages where core summaries and quick-start guidance live via the main site index at Gentle Clearing 51's introduction.
References to editorial best practice
On evidence grading and transparent methods, high-level approaches align with guidelines commonly used in clinical evidence synthesis; for a primer see the National Institutes' overview on evidence hierarchies (evidence-based medicine).